Methodological approach to depressive symptoms in fibromyalgia patients

Clinical and Experimental Rheumatology

Volumn 30, Issue SUPPL.74, 2012, Pages

  Veltri, Antonello ^a   Scarpellini, Pietro ^a   Piccinni, Armando ^a   Conversano, Ciro ^a   Giacomelli, Camillo ^a   Bombardieri, Stefano ^a   Bazzichi, Laura ^a   Dell'Osso, Liliana ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Depression; Fibromyalgia; Mood spectrum; Rating scales; Sub threshold symptoms

Indexed keywords

BECK DEPRESSION INVENTORY; CENTER FOR EPIDEMIOLOGIC STUDIES DEPRESSION SCALE; CHRONIC PAIN; CHRONIC PATIENT; DEPRESSION; DISEASE SEVERITY; FIBROMYALGIA; HAMILTON SCALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MODEL; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MOOD SPECTRUM SELF REPORT; PATIENT ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; REVIEW; SCORING SYSTEM; ZUNG SELF RATING DEPRESSION SCALE; AFFECT; COMORBIDITY; DISABILITY; PAIN ASSESSMENT; PREDICTIVE VALUE; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE;

AFFECT; CHRONIC PAIN; COMORBIDITY; DEPRESSION; DISABILITY EVALUATION; FIBROMYALGIA; HUMANS; PAIN MEASUREMENT; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 84874951806     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. BENNETT RM, SMYTHE HA, WOLFE F, Recognizing fibromyalgia. Patient Care 1989; 23, 60-83.
2. BAZZICHI L, SERNISSI F, CONSENSI A et al., Fibromyalgia, a critical digest of the recent literature. Clin Exp Rheumatol 2011; 29 (Suppl. 69), S1-11.
3. WOLFE F, SMYTHE HA, YUNUS MB et al., The American College Of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33, 160-72.
4. WOLFE F, HAWLEY DJ, Measurement of the quality of life in rheumatic disorders using the EuroHRQoL. Br J Rheumatol 1997; 36, 786-93.
5. MARTINEZ JE, FERRAZ MB, SATO EI, ATRA E, Fibromyalgia versus rheumatoid arthritis, a longitudinal comparison of the quality of life. J Rheumatol 1995; 22, 270-4.
6. PINCUS T, MACLEAN R, YAZICI Y, HARRINGTON JT, Quantitative measurement of patient status in the regular care of patients with rheumatic diseases over 25 years as a continuous quality improvement activity, rather than traditional research. Clin Exp Rheumatol 2007; 25, 69-81.
7. ARNOLD LM, HUDSON JI, HESS EV et al., Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry 2006; 67, 1219-25.
8. WILKE WS, GOTA CE, MUZINA DJ, Fibromyalgia and bipolar disorder, a potential problem? Bipolar Disord 2010; 12, 514-20
9. AGUGLIA A, SALVI V, MAINA G, ROSSETTO I, AGUGLIA E, Fibromyalgia syndrome and depressive symptoms, comorbidity and clinical correlates. J Affect Disorders 2011; 128, 262-6.
10. MARANGELL LB, CLAUW DJ, CHOY E et al., Comparative pain and mood effects in patients with comorbid fibromyalgia and major depressive disorder, secondary analyses of four pooled randomized controlled trials of duloxetine. Pain 2011; 152, 31-37.
11. HAVILAND MG, BANTA JE, PRZEKOP P, Fibromyalgia, prevalence, course, and co-morbidities in hospitalized patients in the United States, 1999-2007. Clin Exp Rheumatol 2011; 29 (Suppl. 69), S79-87.
12. KATO K, SULLIVAN PF, EVENGARD B, PEDERSEN NL, Importance of genetic influences on chronic widespread pain. Arthritis & Rheumatism 2006; 54, 1682-6.
13. HUDSON JL, ARNOLD LM, KECK PE JR et al., Family study of fibromyalgia and affective spectrum disorder. Biol Psychiatry 2004; 56, 884-91.
14. ARNOLD LM, HUDSON JI, HESS EV et al., Family study of fibromyalgia. Arthritis Rheum 2004; 50, 944-52.
15. GOLDSTEIN BI, HOUCK PR, KARP JF, Factors associated with pain interference in an epidemiologicsample of adults with bipolar I disorder. J Affect Disord 2009; 117, 151-6.
16. WHITE KP, NIELSON WR, HARTH M et al., Chronic widespread musculoskeletal pain with or without fibromyalgia, psychological distress in a representative community adult sample. J Rheumatol 2002; 29, 588-94.
17. WALKER EA, KEEGAN D, GARDNER G et al., Psychosocial factors in fibromyalgia compared with rheumatoid arthritis, 1, psychiatric diagnoses and functional disability. Psychsom Med 1997; 59, 565-71.
18. EPSTEIN SA, KAY G, CLAUW D et al., Psychiatric disorders in patients with fibromyalgia, a multicenter investigation. Psychosomatics 1999; 40, 57-63.
19. ALOK R, Das SK, AGARWAL GG et al., Relationship of severity of depression, anxiety and stress with severity of fibromyalgia. Clin Exp Rheumatol 2011; 29 (Suppl. 69), S70-2.
20. KAPOOR SR, HIDER SL, BROWNFIELD A, MATTEY DL, PACKHAM JC, Fibromyalgia in patients with rheumatoid arthritis, driven by depression or joint damage? Clin Exp Rheumatol 2011; 29 (Suppl. 69), S88-91.
21. MACFARLANE GJ, THOMAS E, PAPAGEORGIOU AC et al., The natural history of chronic pain in the community, a better prognosis than in the clinic? J Rheumatol 1996; 23, 1617-20.
22. SHEEHAN DV, LECRUBIER Y, SHEEHAN KH et al., The Mini-International Neuropsychiatric Interview (M.I.N.I.), the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 (Suppl. 20), 22-33.
23. FIRST MB, SPITZER RL, WILLIAMS JBW, GIBBON M, Structured Clinical Interview for DSM-IV-Patient Edition (SCID-P). Washington, DC, American Psychiatric Press; 1995.
24. SHERBOURNE CD, WELLS KB, HAYS RD, ROGERS W, BURNAM MA, JUDD LL, Subthreshold depression and depressive disorder, clinical characteristics of general medical and mental health specialty outpatients. Am J Psychiatry 1994; 151, 1777-84.
25. OLFSON M, BROADHEAD WE, WEISSMAN MM et al., Sub-threshold psychiatric symptoms in a primary care group practice. Arch Gen Psychiatry 1996; 53, 880-6.
26. JUDD LL, AKISKAL HS, ZELLER PJ, PAULUS MJ, LEON AC, MASER JD, Psychosocial disability during the long-term course of unipolar major depressive disorder. Arch Gen Psychiatry 2000; 57, 375-80.
27. DELL'OSSO L, ARMANI A, RUCCI P et al., Measuring mood spectrum, Comparison of interview (SCI-MOODS) and self-report (MOODS-SR) instrument. Compr Psychiatry 2002; 43, 69-73.
28. BOOMERSHINE CS, A comprehensive evaluation of standardized assessment tools in the diagnosis of fibromyalgia and in the assessment of fibromyalgia severity. Pain Res Treat 2012; 2012, 653-714.
29. CARVILLE SF, CHOY EH, Systematic review of discriminating power of outcome measures used in clinical trials of fibromyalgia. J Rheumatol 2008; 35, 2094-105.
30. CHOY EH, ARNOLD LM, CLAUW DJ et al., Content and criterion validity of the preliminary core dataset for clinical trials in fibromyalgia syndrome. J Rheumatol 2009; 36, 2330-4.
31. HAMILTON M, A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23, 56-62.
32. ZIGMOND AS, SNAITH RP, The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67, 361-70.
33. RADLOFF LS, The CES-D scale, a self-report depression scale for research in the general population. Appl Psychol Measure 1977; 1, 385-401.
34. BECK AT, WARD CH, MENDELSON M et al., An inventory for measuring depression. Arch Gen Psychiatry 1961; 4, 561-71.
35. MONTGOMERY SA, ASBERG M, A new depression scale, designed to be sensitive to change. Br J Psychiatry 1979; 134, 382-9.
36. ZUNG WW, RICHARDS CB, SHORT MJ, Selfrating depression scale in an outpatient clinic. Further validation of the SDS. Arch Gen Psychiatry 1965; 13, 508-15.
37. GUY W, ECDEU Assessment manual for psychopharmacology-revised. DHEW Publ No. (ADM) 76-338. Rockville, MD, US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs; 1976, 217-22.
38. LINDEN M, BORCHELT M, BARNOW S et al., The impact of somatic morbidity on the Hamilton Depression Rating Scale in the very old. Acta Psychiatr Scand 1995; 92, 150-4.
39. ZIMMERMAN M, POSTERNAK MA, CHELMINSKI I, Is it time to replace the Hamilton Depression Rating Scale as the primary outcome measure in treatment studies of depression? J Clin Psychopharmacol 2005; 25, 105-10
40. SNAITH RP, ZIGMOND AS, Hospital Anxiety and Depression Scale (HADS). In, RUSH AJ editor. Handbook of Psychiatric Measures. Washington DC, American Psychiatric Association; 2000, 547-8.
41. BJELLARD I, DAHL AA, TANGEN HAUG T et al., The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002; 52, 69-77.
42. JOHNSTON M, POLLARD B, HENNESSEY P, Construct validation of the hospital anxiety and depression scale with clinical populations. J Psychosom Res 2000; 48, 579-84.
43. WEISSMAN MM, SHOLOMSKAS D, POTTENGER M et al., Assessing depressive symptoms in five psychiatric populations, a validation study. Am J Epidemiol 1977; 106, 203-14.
44. SHUMWAY M, SENTELL T, UNICK G et al., Cognitive complexity of self-administered depression measures. J Affect Disord 2004; 83, 191-8.
45. DEVINS GM, ORME CM, COSTELLO CG et al., Measuring depressive symptoms in illness populations, psychometric properties of the Center for Epidemiologic Studies Depression (CES-D). Psychol Health 1988; 2, 139-56.
46. SHEEHAN TJ, FIFIELD J, REISINE S et al., The measurement structure of the Center for Epidemiologic Studies Depression Scale. J Pers Assess 1995; 64, 507-21.
47. BEEKMAN AT, DEEG DJ, VAN LIMBEEK J et al., Criterion validity of the Center for Epidemiologic Studies Depression scale (CESD), results from a community-based sample of older subjects in The Netherlands. Psychol Med 1997; 27, 231-5.
48. PARIKH RM, EDEN DT, PRICE TR et al., The sensitivity and specificity of the Center for Epidemiologic Studies Depression Scale in screening for post-stroke depression. Int J Psychiatry Med 1988; 18, 169-81.
49. SCHEIN RL, KOENIG HG, The Center for Epidemiological Studies-Depression (CESD) scale, assessment of depression in the medically ill elderly. Int J Geriatr Psychiatry 1997; 12, 436-46.
50. BECK AT, STEER RA, BROWN GK, BDI-II. Beck Depression Inventory. 2nd ed. San Antonio, Psychological Corporation, 1996.
51. WILLIAMS AC, RICHARDSON PH, What does the BDI measure in chronic pain? Pain 1993; 55, 259-66
52. BECK AT, STEER RA, GARBIN MG, Psychometric properties of the Beck Depression Inventory, twenty-five years of evaluation. Clin Psychol Rev 1988; 8, 77-100.
53. RICHTER P, WERNER J, HEERLEIN A et al., On the validity of the Beck Depression Inventory; a review. Psychopathology 1998; 31, 160-8.
54. GOLD SM, ZAKOWSKI SG, VALDIMARSDOTTIR HB et al., Higher Beck depression scores predict delayed epinephrine recovery after acute psychological stress independent of baseline levels of stress and mood. Biol Psychol 2004; 67, 261-73.
55. RICHTER P, WERNER J, BASTINE R et al., Measuring treatment outcome by the Beck Depression Inventory. Psychopathology 1997; 30, 234-40.
56. DAVIDSON J, TURNBULL CD, STRICKLAND R et al., The Montgomery Åsberg Depression Scale, reliability and validity. Acta Psychiatr Scand 1986; 73, 544-8.
57. ASBERG M, MONTGOMERY SA, PERRIS C et al., A comprehensive psychopathological rating scale. Acta Psychiatr Scand 1978; 58 (Suppl. 271), 5-27.
58. SNAITH RP, HARROP FM, NEWBY DA et al., Grade scores of the Montgomery Asberg Depression and the Clinical Anxiety Scales. Br J Psychiatry 1986; 148, 599-601.
59. ZUNG WWK, A self-rating depression scale. Arch Gen Psychiatry 1965; 12, 63-70.
60. ZUNG WWK, From art to science, the diagnosis and treatment of depression. Arch Gen Psychiatry 1973; 29, 328-37.
61. ZUNG WWK, The measurement of affects, depression and anxiety. Mod Probl Pharmacopsychiatry 1974; 7, 170-88.
62. HEDLUND JL, VIEWEG BW, The Zung Self-Rating Depression Scale, a comprehensive review. J Operat Psychiatry 1979; 10, 51-64.
63. OKIMOTO JT, BARNES RF, VEITH RC et al., Screening for depression in geriatric medical patients. Am J Psychiatry 1982; 139, 799-802.
64. TURNER JA, ROMANO JM, Self-report screening measures for depression in chronic pain patients. J Clin Psychol 1984; 40, 909-13.
65. RAFT D, SPENCER RF, TOOMEY T et al., Depression in medical outpatients, use of the Zung scale. Dis Nerv Syst 1977; 38, 999-1004.
66. BRODATY H, LUSCOMBE G, PEISAH C et al., A 24-year longitudinal, comparison study of the outcome of depression. Psychol Med 2001; 31, 1347-59.
67. TANAKA-MATSUMI J, KAMEOKA VA, Reliabilities and concurrent validities of popular self-report measures of depression, anxiety, and social desirability. J Consult Clin Psychol 1986; 54, 328-33.
68. PINCUS T, WILLIAMS A, Models and measurements of depression in chronic pain. J Psychosom Res 1999; 47, 211-9.
69. WEDDING U, KOCH A, RÖHRIG B et al., Requestioning depression in patients with cancer, contribution of somatic and affective symptoms to Beck's Depression Inventory. Ann Oncol 2007; 18, 1875-81.
70. TRENTINI CM, XAVIER FM, CHACHAMOVICH E, ROCHA NS, HIRAKATA VN, FLECK MP, The influence of somatic symptoms on the performance of elders in the Beck Depression Inventory (BDI). Rev Bras Psiquiatr 2005; 27, 119-23.
71. PINCUS T, GRIFFITH J, PEARCE S, ISENBERG D, Prevalence of self-reported depression in patients with rheumatoid arthritis. Br J Rheumatol 1996; 35, 879-83.
72. RHEE SH, PETROSKI GF, PARKER JC et al., A confirmatory factor analysis of the Center for Epidemiologic Studies Depression Scale in rheumatoid arthritis patients, additional evidence for a four-factor model. Arthritis Care Res 1999; 12, 392-400.
73. JUDD LL, AKISKAL HS, The prevalence and disability of bipolar spectrum disorders in the US population, re-analysis of the ECA database taking into account sub-threshold cases. J Affect Disord 2003; 73, 123-31.
74. FRANK E, CASSANO GB, SHEAR MK et al., The spectrum model, A more coherent approach to the complexity of psychiatric symptomatology. CNS Spectr 1998; 3, 23-34.
75. CASSANO GB, RUCCI P, FRANK E et al., The mood spectrum in unipolar and bipolar disorder, arguments for a unitary approach. Am J Psychiatry 2004; 161, 1264-9.
76. DELL'OSSO L, PINI S, MAGGI L et al., Subthreshold mania as predictor of depression during interferon treatment in HCV+ patients without current or lifetime psychiatric disorders. J Psychosom Res 2007; 62, 349-55.
77. BAZZICHI L, MASER J, PICCINNI A et al., Quality of life in rheumatoid arthritis, impact of disability and lifetime depressive spectrum symptomatology. Clin Exp Rheumatol 2005; 23, 783-8.
78. PICCINNI A, MASER JD, BAZZICHI L et al., Clinical significance of lifetime mood and panic- agoraphobic spectrum symptoms on quality of life of patients with rheumatoid arthritis. Compr Psychiatry 2006; 47, 201-8.
79. DELL'OSSO L, BAZZICHI L, CONSOLI G et al., Manic spectrum symptoms are correlated to the severity of pain and the health-related quality of life in patients with fibromyalgia. Clin Exp Rheumatol 2009; 27 (Suppl. 56),S57-61.
80. PICCINNI A, BAZZICHI L, MARAZZITI D et al., Sub-threshold mood symptoms in patients with fibromyalgia and rheumatoid arthritis. Clin Exp Rheumatol 2011; 29 (Suppl. 69), S55-9.